Imprimer

Commented Codex Pharma - Public Health in Belgium - Medicinal Products 2012 - Codex of Directly Applicable European Texts

Déscription

Informations techniques

Publications à consulter

Commented Codex Pharma – Public Health in Belgium (Medicinal Products) Codex of Directly Applicable

European Textspharma.be (AGIM) is a non-profit organisation founded in 1966 with the object of representing the interests of the medicines industry in Belgium. About 150 pharmaceutical companies based in Belgium make up its membership. Its mission is to try and create a favourable economic climate in which research and development of new medicines is a priority. pharma.be is thus active at all three stages in the life of a medicinal product: research (human experimentation and clinical trials); marketing of the medicine (public health); price and reimbursement (social and economic affairs).

The Commented Codex Pharma seeks to be a practical tool in the field of Belgian public health regulation (medicines) for its members and all the pharmaceutical sector players, namely the regulatory authorities, doctors, veterinary practitioners, pharmacists, wholesalers, hospitals, and of course employees of the Federal Agency for Medicines and Health Products.

This Codex covers four specific fields that are regulated by four European Regulations that are applicable directly in the Belgian legal system:
1° Regulation (EC) No 141/2000 of the European Parliament and of the Council of 16 December 1999 on orphan medicinal products,
2° Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 2006 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency,
3° Regulation (EC) No 1901/2006 of the European Parliament and of the Council of 12 December 2006 on medicinal products for paediatric use and amending Regulation (EEC) No 1768/92, Directive 2001/20/EC, Directive 2001/83/EC and Regulation (EC) No 726/2004,
4° Regulation (EC) No 1394/2007 of the European Parliament and of the Council of 13 November 2007 on advanced therapy medicinal products and amending Directive 2001/83/EC and Regulation (EC) No 726/2004.

In addition to a consolidated version of the European texts applicable directly in Belgium, this Codex contains a general commentary on each of these texts. After the Codex Pharma, a collection of the most pertinent regulatory texts in the field of public health (medicines), and the Codex Pharma Commenté/Becommentarieerde Codex Pharma, this work constitutes the third stage in the Codex Pharma collection.

Links:

Les codes de notre Catalogue ont été réalisés grâce à une collaboration entre le rédacteur et moncode.be.
Le contenu provient de sources publiques, fournies par le rédacteur.
Ni moncode.be ni le rédacteur ne sont responsables du contenu de ces codes.

Info

prix inc. TVA:

TVA: print 6%, e-book 6%

ISBN: 978-9-4603-5232-4

Expédition: 10 jours après paiement


Notre top 5

Codex pour la pratique comptable (ancien Codex IPCF)

Codex pour la pratique comptable (ancien Codex IPCF)

Procederen voor het Hof van Cassatie/ Procéder devant la Cour de cassation 2016

Procederen voor het Hof van Cassatie/ Procéder devant la Cour de cassation 2016

Douanes et accises - Recueil janvier 2019

Douanes et accises - Recueil janvier 2019

Incidence des procedures collectives d insolvabilite sur les droits d execution des creanciers individuels

Incidence des procedures collectives d insolvabilite sur les droits d execution des creanciers individuels

RFP/TBF - Revue Fiscalité des Placements / Tijdschrift Beleggingsfiscaliteit

RFP/TBF - Revue Fiscalité des Placements / Tijdschrift Beleggingsfiscaliteit


RESPECT DE LA VIE PRIVEE | CONDITIONS GENERALES DE VENTE | Tous les prix affichés sont en euros (EUR).
©2010 KNOPS PUBLISHING Tout droit réservé.